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Opposite, binary regulatory pathways involved in IL-i-mediated
stromelysin gene expression in rat mesangial cells. Glomerular mesangial
cells express matrix metalloproteinase stromelysin in response to the
proinflammatory cytokine IL-lp. The present study was conducted to
identify intracellular machinery involved in this IL-i action, especially
focusing on the role of the TPA response element (TRE) located in the
5'-fianking region of the stromelysin gene. Using transient transfection
with a pTRE-LacZ reporter plasmid, we detected no obvious up-regula-
tion of TRE activity in rat mesangial cells following the IL-i stimulation.
However, the basal activity of TRE was found to be essential to the
stromelysin induction, since (i) mesangial cells stably expressing a trans-
dominant negative mutant of c-Jun, which effectively suppressed both
basal and inducible TRE activity, exhibited the blunted expression of
stromelysin in response to IL-l/3, whereas (ii) transfection with a c-fos
antisense gene, which suppressed only the inducible TRE activity, did not
affect the stromelysin induction. To seek cooperative pathways required
for the IL-i action, we next focused on protein kinases, the potential
regulators of the stromelysin gene. Stimulation of mesangial cells with a
protein kinase C (PKC) activator, phorbol 12-myristate 13-acetate (PMA),
induced the stromelysin transcript without affecting TRE activity. Deple-
tion of intracellular PKC by high-dose PMA or inhibition of PKC activity
with calphostin C suppressed the stromelysin induction by iL-1, suggest-
ing the crucial contribution of a PKC-mediated, but TRE-independent
pathway. in contrast, either cAMP inducer forskolin or dibutyryl cAMP
suppressed the IL-i-mediated stromelysin expression. An inhibitor of
cAMP-dependent protein kinase A (PKA), HA1004, enhanced the IL-I
effect in a dose-dependent manner. Unexpectedly, the inhibitory action of
PKA was not through cAMP response element (CRE) but through TRE,
because (i) activation of CRE was not induced by IL-lp, and (ii)
cAMP-mediated activation of PKA suppressed the basal TRE activity.
These findings elucidated the unique, binary regulation of stromelysin by
IL-113; that is, IL-i up-regulated the transcript via the PKC-dependcnt
pathway under the cooperation with constitutively active TRE, and this
stimulatory effect was in part counterbalanced by the IL-i-inducible PKA
which down-regulated the basal TRE activity.
Matrix metalloproteinases (MMPs) have been implicated in
various pathophysiological conditions such as wound healing,
bone remodeling, arthritis and tumor invasion/metastasis [1]. In
the glomerulus, certain types of MMP are constitutively expressed
and, conceivably, participate in the normal turnover of mesangial
matrix and basement membrane [2, 3]. In pathological situations
glomerular MMPs are often up-regulated, and the accelerated
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matrix breakdown may contribute to destruction of glomerular
architecture as well as to abnormal behavior of glomerular cells
[4—6]. Several mediators, especially inflammatory cytokines, in-
duce MMPs in glomerular cells. For example, mesangial cells
abundantly express MMP-9 (gelatinase B) and stromelysin (tran-
sin) in response to the pro-inflammatory cytokine IL-lp [2, 7, 8].
However, currently little is understood about intracellular events
involved in the cytokine-mediated induction of MMPs in mesan-
gial cells. We recently reported that expression of MMP-9 by
IL-ip is regulated through c-Jun/activator protein-i (AP-i) and
tyrosine kinase-nuclear factor-KB (NF-KB) pathways [8]. In this
report, we aimed to address signal transduction systems involved
in the expression of another IL-i-inducible MMP, stromelysin.
The 5 '-flanking region of the stromelysin gene is known to
contain a 12-o-tetradecanoylphorbol-13-acetate (TPA) response
element (TRE), the binding site of AP-i [9]. AP-1 is a family of
transcription factors composed of dimeric Jun and/or Fos. These
homodimers or heterodimers bind to TRE and up-regulate tran-
scription. In mesangial cells, IL-i induces c-jun and c-fos [8, 10]
and thereby have the potential for activation of TRE. In this
study, we first examined whether or not the activation of TRE is
associated with the up-regulation of stromelysin by IL-lp.
Protein kinase C (PKC) is known to be activated by IL-i in
several cell types [11, 12]. This molecule is a crucial regulator of
AP-1 and involved in growth factor-mediated induction of strome-
lysin in fibroblasts [13]. Although in mesangial cells induction of
MMP-9 and monocyte chemoattractant protein-i by IL-i is
independent of PKC [8, 14], we next examined the role of this
protein kinase in the IL-i-mediated stromelysin induction.
During the course of the study, we found that a non-specific
protein kinase inhibitor enhanced the stromelysin induction by
IL-1f3. We speculated that a certain protein kinase might coun-
teract against the up-regulation of stromelysin by IL-113. To
elucidate the molecules responsible for this negative regulation,
the focus became cAMP-dependent protein kinase (protein ki-
nase A; PKA), since cAMP is induced by IL-I in some cell types
[111 and may be a potential suppressor of cytokine/oncogene-
inducible stromelysin expression [15—i7]. cAMP is generated by
membrane-associated adenylate cyciase and induces activation of
PKA. Activated PKA modulates the function of a nuclear factor,
cAMP response element modulator (CREM), which binds to the
cAMP response element (CRE), and thereby initiates transcrip-
tion [18]. Although CRE is not located in the 5'-regulatory region
of the stromelysin gene [iS], the cAMP-PKA pathway triggered by
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IL-1/3 may be a potential machinery which attenuates the strome-
lysin expression indirectly.
Using genetic and pharmacological modulators for signaling
molecules, this study demonstrates the opposite, binary regulatory
pathways involved in IL-i-mediated stromelysin expression in rat
mesangial cells. TRE is the crucial target for the dual regulation.
Basal activity of TRE contributes to the stromelysin induction
under the cooperation with PKC, and this stimulatory pathway is
in part counteracted by the IL-i-inducible PKA via down-regula-
tion of the basal TRE activity.
Methods
Mesangial cells
Rat mesangial cells were established from isolated glomeruli of
an adult male Sprague-Dawley rat (body weight 200 g), as
described previously [19]. Since cultured mesangial cells may
contain heterogeneous populations, we established a cell clone
SM43 by a limiting dilutional method and identified as being of
mesangial cell phenotype as described [201. Cells were maintained
in Dulbecco's MEM/F-12 (DME-F12; GIBCO BRL, Gaithers-
burg, MD, USA) supplemented with 100 U/mI penicillin G, 100
jig/ml streptomycin, 0.25 ig/ml of amphotericin B, and 10% fetal
calf serum (FCS; GIBCO BRL). DME-F12 containing 1% FCS
was generally used as a basal culture medium for assays.
A transfected mesangial cell clone, JUNDN1, which stably
expresses a transdominant negative mutant of c-Jun, was gener-
ated as follows. TAM-67 is a deletion mutant which is lacking
amino acids 3 to 122 of c-Jun [211. The protein encoded by this
truncated Jun gene retains the DNA binding and leucine zipper
domains but lacks the transactivating domain. Overexpression of
TAM-67, therefore, inhibits AP-1-mediated transactivation via
blocking formation or binding of functional AP-1 complexes in a
transdominant negative fashion [211. Using a modified calcium
phosphate co-precipitation method, SM43 cells (5 >< 10) were
co-transfected with 10 tg of pCMV-TAM67 [22] encoding the
mutated c-jun and 1 jg of pRc/CMV (Invitrogen, San Diego, CA,
USA), which introduces a neomycin phosphotransferase gene, as
described before [5]. Stable transfectants were selected in the
presence of neomycin analogue G418 (0.75 mg/mI; Sigma, Dorset,
UK). Expression of the transgene was confirmed by Northern blot
analysis, and JUNDNI was established.
An expression plasmid pH/3F0sAS-neo that introduces an
antisense c-fos was constructed by subcloning of the BamHI-SalI
fragment of c-fos from p75'15 [23] into the SalI-BamHl sites of
pHApr-1-neo [24] in an antisense orientation. SM43 mesangial
cells were transfected with 10 .tg of the pHI3F0sAS-neo, selected
by G418, and a stable transfectant FOSAS1 was established.
Efficient inactivation of AP-1 in these established transfectants
was confirmed by evaluating TRE activity using transient trans-
fection with a TRE reporter plasmid, as described below. The
functional specificity of the transdominant negative mutant of
c-Jun in JUNDN1 cells was also investigated by evaluating the
NF-KB activation in response to IL-lp [8]. For this purpose, a KB
reporter plasmid pHIVLTRI3-gal [25] was utilized. This construct
introduces a bacterial p-galactosidase gene (lacZ) under the
control of a human immunodeficiency virus (HIV) promoter
which contains two KB motifs. With a calcium phosphate co-
precipitation method, JUNDN1 cells and mock transfectants
cultured in 24-well culture plates (1.5 X i0 cells/well) were
transiently transfected with pHIVLTR-gal (80 ng/well) or a
control plasmid pmuHIVLTRj3-gal, which contains a KB-mutated
HIV promoter. After 48 hours, cells were stimulated by IL-lp (5
ng/ml, human recombinant; Otsuka Pharmaceutical Co, Ltd.,
Tokushima, Japan) for 24 hours and subjected to X-gal (5-bromo-
4-chloro-3-indolyl f3-o-galactopyranoside; Sigma) assay [20] to
detect p-galactosidase activity. This is described in detail below.
Pharmacological manipulation
To investigate the action of IL-1j3, confluent mesangial cells
were incubated in 1% FCS/DME-F12 for 48 hours and exposed to
5 ng/ml of IL-1J3 for 24 hours. The role of PKC was investigated
by stimulating the cells with a PKC activator phorbol 12-myristate
13-acetate (PMA; 30 ng/ml, Sigma) for 24 hours, or by pretreating
with high-dose PMA (300 ng/ml; 24 hr) or a specific PKC
inhibitor, calphostin C (250 to 500 nM; 3 hr; Calbiochem-Nova-
biochem Ltd., Nottingham, UK), prior to the IL-i stimulation [8].
To examine the role of the cAMP-PKA pathway, cells were
pretreated with a c-AMP inducer forskolin (1 to 10 pvi; ICN
Pharmaceuticals Ltd., Oxfordshire, UK), a cAMP analogue N6,2'-
o-dibutyryladenosine 3':S'-cyclic monophosphate (dibutyryl
cAMP; 50 to 100 M, Sigma), or a PKA inhibitor N-(2-guanidi-
noethyl)-5-isoquinoline sulfonamide (HA1004; ito 10 M, Sigma)
for 1.5 hours and then stimulated by IL-lp.
Assessment of TRE and CRE activities
To evaluate the activity of TRE and CRE, reporter plasmids
pTRE-LacZ and pCRE-LacZ [26] were utilized, as described
previously [8, 27]. These constructs introduce lacZ under the
control of TRE or CRE so that the activity of each response
element can be monitored via ,!3-galactosidase expression. Mesan-
gial cells cultured in 24-well culture plates (1.5 X i0 cells/well)
were transiently transfected with each plasmid (80 ng/well) using
the calcium phosphate co-precipitation method and, after 72
hours, subjected to X-gal assay to detect p-galactosidase activity
[20]. In brief, cells were fixed in 0.5% glutaraldehyde, 2 mM
MgC12, and 1.25 mM EGTA in PBS for 15 minutes and incubated
at 37°C for two hours in a reaction buffer containing 1 mg/mI
X-gal, 20 m'vi K3Fe(CN)6, 20 mM K4Fe(CN)( 3H20, 2 mM
MgCI2, 0.01% sodium desoxycholate, and 0.02% NP-40 in PBS.
The activity of TRE and CRE was assessed by counting blue cells
stained by X-gal under the field of a light microscope. In some
experiments, the cells transfected with the reporter plasmids were
stimulated by IL-lp for 24 hours prior to X-gal assay.
To examine the TRE activity in stably transfected mesangial
cells, a pharmacological stimulator of AP-1/TRE, pyrrolidine
dithiocarbamate (PDTC, Sigma), was used [27, 28]. Untransfected
cells, JUNDN1 or FOSAS1 were treated with or without 50 gtvi
PDTC for 24 hours, and TRE activity was assessed by transient
transfection with pTRE-LacZ, as described above. To exclude the
influence of clonal variability in transfection efficiency, the num-
ber of X-gal-positive cells in each group was normalized by the
number of X-gal-positive cells transfected with a control expres-
sion plasmid pCXL [29]. All the transfection experiments were
performed in quadruplicate.
Northern blot analysis
Total RNA was extracted by a single-step method [301, and
Northern blot analyses were performed as described before [31].
The RNA samples (10 jLg/lane) were electrophoresed on 1.2%
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Fig. 1. Effect of IL-1f3 on the activity of 12-o-tetradecanoylphorhol-13-
ace/ate (TPA) response element (TRE). Rat mesangial cells cultured in
24-well plates (1.5 x i0 cells/well) were transiently transfected with a
TRE reporter plasmid pTRE-LacZ using a calcium phosphate co-precip-
itation method. After 48 hours, the cells were stimulated by IL-Ill (5
ng/ml) for 24 hours, and X-gal (5-hromo-4-chloro-3-indolyl -D-galacto-
pyranoside) assay was performed to detect j3-galactosidase expression. For
a positive control experiment, a pharmacological activator of TRE,
pyrrolidine dithiocarbamate (PDTC; 50 .rM) was used. Activity of TRE
was evaluated by counting X-gal-positive cells under the field of a
microscope. Assay was performed in quadruplicate, and data are pre-
sented as means SE. An asterisk indicates statistically significant
difference (P < 0.05) compared to unstimulated control cells (—).
agarose gels and transferred onto nitrocellulose membranes
(Schleicher & Shuell, Dassel, Germany). For the hybridization,
each probe was labeled with 32P-dCTP using a random priming
method. The membranes were hybridized with probes at 65°C
overnight in a solution containing 4 X SSC (600 mivi NaCI, 60 mM
sodium citrate), 5x Denhardt's solution, 10% dextran sulfate, 50
jrg/ml herring sperm DNA and 50 j.rg/ml poly (A) washed four
times in 4 X SSC/0.1% SDS at 50°C and exposed to Kodak XAR
films at —80°C. A rat stromelysin eDNA [321, a human c-fos
eDNA [131, and a mutated human c-jun cDNA [211 were used as
probes.
Statistical analysis
All experiments were repeated two to four times, and repre-
sentative results are shown. Data were expressed as means SE.
Statistical analysis was performed using the two sample t test to
compare data in different group of cells. A P value less than 0.05
was used to indicate a statistically significant difference.
Results
Contribution of AP-1 and TRE
IL-1 has an ability to induce c-jun and c-fos in SM43 mesangial
cells [1 To elucidate the role of AP-1 and TRE in the induction
of stromelysin by IL-lp, we first examined the TRE activity in
mesangial cells under both unstimulated and IL-I-stimulated
conditions. Transient transtection with a reporter plasmid re-
vealed that TRE was constitutively active in unstimulated mesan-
gial cells mainteined in the basal assay medium containing 1%
FCS (Fig. 1). This was defined as "basal TRE activity." This basal
activity was not affected by IL-1/3 [92.7 3.7% versus unstimu-
lated state (100%), mean sEl whereas it was significantly
up-regulated by the AP-1 stimulator, PDTC (147.6 7.6% vs.
control, P < 0.05). This result suggested that additional activation
of TRE is not required for the induction of stromelysin by IL-1/3.
To confirm this further, the stable transfectant FOSAS1 was
utilized. This mesangial cell clone expressed 2.5 kb mRNA
corresponding to the antisense transcript of c-fos (Fig. 2A).
Transient transfection study with a pTRE-LacZ plasmid revealed
that the expressed antisense gene did not affect the basal TRE
activity, but markedly suppressed the PDTC-inducible TRE acti-
vation (Fig. 2B). Compared to mock transfected cells, 78.6
7.1% of inducible TRE activity was abrogated by the transfection
with the c-fos antisense gene. Using this transfectant, induction of
stromelysin by IL-lp was examined. Northern blot analysis
showed no obvious alteration in the expression levels of strome-
lysin in FOSAS1 cells compared to mock transfectants (Fig. 2C).
This finding further supported the above result that additional
activation of TRE is not involved in the IL-i-mediated stromely-
sin induction.
Under the basal culture condition, cultured rat mesangial cells
express c-jun but not c-fos [8, 27]. The homodimer of c-Jun
conceivably contributes to the basal TRE activity [33]. To examine
whether the basal activity of TRE is required for the IL-i action,
we utilized JUNDN1 cells stably expressing a transdominant
negative mutant of c-Jun. Northern blot analysis showed that the
JUNDN1 expressed 0.9 kb of a transgene transcript (Fig. 3A).
Transient transfection assay revealed that the expressed mutant
gene was functional, since TRE activity was significantly repressed
under both unstimulated and PDTC-stimulated conditions (Fig.
3B). The TRE activity was reduced to 72.4 3.4% in unstimu-
lated state and to 45.6 3.5% in the PDTC-stimulated condition
compared with the values of mock transfected cells (100%, P <
0.05). The suppressive action of the transgene was restricted to
TRE, since as shown in Figure 3C, activation of the KB site
triggered by IL-113 was unaffected in JUNDNI cells; that is,
compared to the unstimulated state (100%), activation of the KB
site by IL-113 was 205.0 18.0% in mock transfectants and
203.1 26.5% in JUNDN1 cells. Using this clone, the induction
of stromelysin by IL-113 was examined. Northern analysis revealed
that, compared to mock transfectants, the stromelysin expression
was markedly suppressed in the JUNDN1 cells (Fig. 3D). These
data indicated that basal activity of TRE is essential to the
stromelysin induction by IL-1/3.
Involvement of PKC
Basal activity of TRE was found to be required but insufficient
for the induction of stromelysin. Some other signaling pathways
should cooperatively contribute to the IL-i action. To seek the
complementary pathways required, we next focused on PKC, the
potential regulator of the stromelysin gene [13, 161. Stimulation of
mesangial cells with a PKC activator PMA induced stromelysin
transcript (Fig. 4A). Furthermore, depletion of PKC by high-dose
PMA suppressed the stromelysin induction by IL-1f3. The crucial
contribution of PKC was also confirmed by an another pharma-
cological inhibitor caiphostin C. This agent inhibited the IL-i
induction of stromelysin in a dose-dependent manner (Fig. 4B).
Interestingly, PMA-mediated PKC activation did not affect the
TRE activity (Fig. 4C). These data suggested that, without
affecting TRE, IL-i -induced PKC cooperated with some house-
keeping pathway that maintained the basal TRE activity and,
thereby, induced stromelysin transcription.
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Fig. 2. Induction of stromelysin by IL-1/3 in mesangial cells stably trans-
fected with a c-fos antisense gene. Mesangial cells were transfected with an
expression plasmid pHI3F0sAS-neo which introduces antisense c-fos, and
a stable transfectant FOSASI was established. Mesangial cells transfected
with pH/3Apr-1-neo was used as a mock transfectant (Mock). A. Northern
blot analysis of transgene transcript. Position of ribosomal RNAs (28S and
18S) is indicated on thc right. Expression of /3-actin is shown as a loading
control. B. Assessment of TRE activity in FOSAS1 cells. pTRE-LacZ was
transiently transfected into mock transfected cells (L]) or FOSASI cells(). After 48 hours, the cells were treated with (+) or without (—) PDTC
for 24 hours and subjected to X-gal assay. To exclude the influence of
clonal variability in transfection efficiency, the number of X-gal-positive
cells in each group was normalized by the number of X-gal-positive cells
transfected with a control expression plasmid pCXL. The relative ratios
(TRE-LacZ/CXL) are shown as "Normalized X-gal positivity." Data arc
presented as means SE. An asterisk indicates statistically significant
difference (P < 0.05). C. Stromelysin expression in FOSAS1 cells stimu-
lated by IL-I /3. Mock transfected cells and FOSASI cells were treated with
(+) or without (—) IL-1/3, and Northern blot analysis was performed on
the stromelysin expression.
Role of PK4
The role of cAMP-responsive PKA in IL-i-mediated stromely-
sin expression was investigated because cAMP is induced by IL-i
irs some cell types [11] and may be a potential suppressor of
cytokine/oncogene-inducible stromelysin expression [15—17].
Mesangial cells were pretreated with a cAMP inducer forskolin or
dibutyryl cAMP and stimulated by IL-1f3. Northern blot analysis
revealed that both agents effectively suppressed the stromelysin
induction in a dose-dependent manner (Fig. 5 A, B). To examine
whether the cAMP-PKA pathway is activated by IL-i and mod-
ulates the stromelysin expression, mesangial cells were pretreated
with a PKA inhibitor HA1004 and then stimulated by IL-1f3. As
shown in Figure SC, HAl 004 enhanced the expression of strome-
lysin dose dependently. Under the unstimulated condition,
HAl 004 alone had no impact on the stromelysin expression (data
not shown). These findings suggested that PKA was implicated in
the IL-i action as a negative regulator of stromelysin gene
expression.
Generally, cAMP-dependent PKA regulates target gene tran-
scription via CRE. We therefore examined the effect of IL-1/3 on
the activity of CRE using transient transfection with a reporter
plasmid pCRE-LacZ. Under the unstimulated condition, mesan-
gial cells exhibited no CRE activity (Fig. 6A). Stimulation with
dibutyryl cAMP markedly induced activation of CRE, whereas
unexpectedly, IL-1/3 did not trigger CRE. Together with the fact
that CRE is not located in the S'-regulatory region of the
stromelysin gene [151, PKA may act as a negative regulator
independently of CRE.
There is a substantial sequence homology between TRE and
CRE [341. It has been reported that CRE binding proteins
(CREB) may have an ability to bind to TRE and inhibit its
activation [35]. To investigate whether TRE is the target of the
PKA action, the effect of dibutyryl cAMP on the basal activity of
TRE was tested in the presence or absence of the PKA inhibitor
HA1004. Transfection with pTRE-LacZ elucidated that dibutyryl
cAMP significantly reduced the basal activity of TRE [53.9
3.3% vs. control (100%); Fig. 6B]. In the presence of HA1004,
however, this reduction was abolished. These findings elucidated
the unique binary regulation of stromelysin by IL-1/3; that is, the
basal TRE activity required for the IL-I action was, in part,
down-regulated by the IL-i-inducible PKA.
Discussion
In this report, we describe the opposite, binary regulatory
pathways involved in IL-i-mediated stromelysin gene expression
in rat mesangial cells. We showed that IL-1/3 up-regulated strome-
lysin via the PKC-dependent pathway under the cooperation with
constitutively active TRE. Interestingly, this stimulatory effect was
found to be, in part, counterbalanced by the IL-i-inducible PKA
which down-regulated the basal TRE activity. A schematic sum-
mary of our results is shown in Figure 7.
To examine the role of AP-1 in the IL-i action, we established
stable transfectants, FOSAS1 and JUNDNI. FOSAS1 stably
expressing the antiscnse transcript of c-fos showed repressed TRE
activity exclusively under the stimulated condition. in contrast,
JUNDN1, which expresses the transdominant negative mutant of
c-Jun, exhibited attenuated TRE activity under both basal and
stimulated conditions. This difference is possibly due to the fact
that rat mesangial cells express c-jun but not c-fos in the basal
culture condition [8, 271. The basal activity of TRE in mesangial
cells is thus maintained by c-Jun/AP-1 constitutively expressed in
response to serum components or some autocrine mediators, as
reported in other cell types 1331 JUNDN1 exhibited a blunted
A
c-fosAS
13-actin
B
— 28S
— 18S
.' 0.6
>
Co0
, 0.4
x
U)N
0.2
0z
(+)
IL—ill (—) (+) (—) (+)
Stromelysin
ll-actin
It-lb I—) .' —) c.)
— a
Moct JUNOftII
— s1 3
-28S
-185
flacir
C
a
Pt
F
2
0
.
.n1
.77T
.ririii
Mcdi ,$JNDN I Mcdi JUNON I
0
pHIVUR Øqal pnMIVIJR
898 Yokoo and Kitamura: Regulation of stromelysin by IL-1/3
>,
>
U)00
C',0)
><
ci)N
cci
E
0z
PDTC (—) (+)
Fig. 3. Induction of stromelysin by IL-ID in mesangial cells stably transfected with a gene encoding a transdominant negative mutant of c-Jun. Mesangial
cells were transfected with an expression plasmid pCMV-TAM67 which introduces a mutated c-fun, and the stable transfectant JUNDN1 was
established. A. Northern blot analysis of transgene transcript. "c-junDN" indicates mRNA of the introduced mutant c-jun. B. Assessment of TRE activity
in JUNDN1 cells. pTRE-LacZ was transiently transfected into mock transfected cells (E:) or JUNDN1 cells (). After 48 hours, the cells were treated
with or without PDTC for 24 hours and subjected to X-gal assay. Asterisks indicate statistically significant differences (P < 0.05). C. Assessment of
activity of the KB site in JUNDNI cells. Functional specificity of the transgene was tested by evaluating activation of the KB site in response to IL-1/3.
Mock transfectants and JUNDN1 cells were transiently transfected with a KB reporter plasmid pHIVLTR-gal or a control plasmid pmuHIVLTRp-gal
which contains a KB-mutated promoter. After 48 hours, cells were stimulated with () or without (t3) IL-1 and subjected to X-gal assay. Data are
presented as means se. Asterisks indicate statistically significant differences (P < 0.05). D. Stromelysin expression in JUNDN1 cells stimulated by
tL-1. Mock transfected cells and JUNDNI cells were treated with (+) or without (—) IL-lp, and Northern blot analysis was performed on the
stromelysin expression.
induction of stromelysin responding to IL-1f3, whereas the re-
sponse in FOSAS1 was unaffected. These findings, together with
the fact that IL-13 did not up-regulate the TRE activity, indicated
that the basal TRE activity is required but its additional activation
is not necessary for the induction of stromelysin by lL-lp. This is
similar to the mechanism involved in TPA-mediated stromelysin
induction in human libroblasts and tumor cell lines [36, 37].
Since the basal activity of TRE is insufficient for the induction
of stromelysin, sonic other pathways should cooperatively mediate
the IL-I action. We identified that the PKC-depcndent but
TRE-independent pathway is one of the essential contributors. In
mesangial cells, the role of PKC in the IL-I signaling is little
understood [101. Generally, IL-i stimulates mesangial cells
through PKC-independent pathways [8, 10, 14, 38]. However, in
this study, we elucidated the crucial contribution of PKC, based
on the data that (i) PKC activation induced stromelysin gene
expression and (ii) depletion or inhibition of intracellular PKC
attenuated the stromelysin induction by lL-113. To our knowledge,
this is one of the earliest reports showing the role of PKC involved
in the IL-i signaling in mesangial cells.
The molecular mechanisms implicated in the stromelysin induc-
tion via PKC are currently unknown. Candidates involved up-
stream (or down-stream) of PKC could be tyrosine kinases [8, 14,
39, 40]. We recently found that, in rat mesangial cells, IL-l/3
induced phosphorylation of tyrosinc and that tyrosine kinase
inhibitors genistcin and herbimycin A effectively suppressed the
IL-i induction of stromclysin gene (our unpublished data). Al-
though the correlation between tyrosine kinases and PKC remains
to be elucidated, tyrosine kinases may be implicated in the
positive regulatory pathway demonstrated here.
Some transacting molecules and their binding sites located in
the stromelysin gene promoter may be involved down-stream of
PKC. It is worthwhile to note that: (i) two copies of a motif similar
to the polyomavirus enhancer A-binding protein-3 (PEA-3) site,
where the Ets family of transcription factors can bind, are located
in the stromelysin gene promoter [37]; (ii) this region is required
Dmelysin •
3-actin
skoOn 0 1 5 10 (jiM
Sysin
-actin
\1004 0
elysin
-actin
1 10 (jiM)
Yokoo and Kitamura: Regulation of stromelysin by IL-i /3 899
A
\V \'J'
Stromelysin
B
For li  (l.t )
f3-actin
Stromel
B
Caiphostin C 0 250 500 (nM) 3
Fig. 5. Role of cAMP-dependent protein kinase A (PIcA) in IL-I -mediated
stromelysin induction. Mesangial cells were pretreated for 1.5 hours with:
(A) a cAMP analogue, N6,2'-o-dibutyryladenosine 3:5-cyclic monnphos-
phate (dibutyryl cAMP) at a concentration of 50 or 100 M; (B) a cAMP
inducer forskolin at 1, 5, or 10 jrM; or (C) a PKA inhibitor N-(2-
guanidinoethyl)-5-isoquinoline sulfonamide (HA1004) at 1 or 10 JSM, and
then stimulated by IL-i/I. After 24 hours, Northern blot analyses were
performed on the stromelysin expression.
mechanism involved in the PKC-dependent but TRE-indepen-
dent regulatory pathway.
In this study, we found that IL-i induction of stromelysin by the
PKC- and TRE-mediated pathways was, in part, counterbalanced
by the IL-i-inducible PKA. This is because either forskolin or
dibutyryl cAMP suppressed the stromelysin induction, and a PKA
inhibitor enhanced the IL-i action dose dependently. This finding
is in agreement with a previous report in human synovial fibro-
blasts [16]. Unexpectedly, however, the inhibitory effect of PKA
was not through CRE but via attenuation of the basal TRE
activity that is essential to the stromelysin induction. The mech-
anism involved in this phenomenon is unkown. One possibility
may he direct modulation of TRE by CRE-accessible transacting
molecules. A substantial sequence homology has been reported
between TRE and CRE [34]. Both cAMP response element
modulator (CREM) and CRE binding proteins (CREB) that
structurally resemble Fos and Jun have an ability to bind to TRE
and, thereby, may inhibit its activation [35]. This evidence implies
that PKA-inducible nuclear factors could directly inhibit TRE
activity and counteract against the stromelysin expression trig-
gered by the positive regulatory pathways.
IL-1f3 induces c-fos and c-jun in mesangial cells [8], and
therefore, the activity of TRE should be up-regulated. However,
in this study, the activity of TRE was unaffected following the IL-i
or PMA stimulation. This is similar to the case of NIH3T3
fibroblasts that exhibit substantial levels of basal TRE activity and
insensitivity to PMA-mediated activation of TRE [44]. A possible
explanation for this may be that IL-I-inducible PKA acted as a
A
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Fig. 4. Role of protein kinase C (PKC) in IL-i-mediated stromelysin
induction. A. Modulation of intracellular PKC and stromelysin expression
by phorbol 12-myristate 13-acetate (PMA). Mesangial cells were treated
for 24 hours with (i) 30 ng/ml of PMA, (ii) 5 nglml of IL-I 13, or (iii) IL-i/I
following pretreatment with 300 nglml of PMA for 24 hours (IL-113+PMA
pret.), and Northern blot analysis was performed on the expression of
stromelysin. (—): unstimulated cells. B. Dose-dependent inhibition of
stromelysin induction by calphostin C. Mesangial cells were pretreated
with a PKC inhibitor calphostin C (250 to 500 nM) for three hours,
stimulated with IL-i/I, and Northern blot analysis was performed. C.
Effect of PKC stimulation on TRE activity. Mesangial cells were tran-
siently transfected with pTRE-LacZ, stimulated by PMA (30 ng/ml) for 24
hours, and X-gal assay was performed. For a positive control study, PDTC
was used as an activator of TRE. Activity of TRE was assessed by counting
X-gal-positive cells per well. An asterisk indicates statistically significant
difference (P < 0.05) compared to unstimulated control cells (—).
for induction of stromelysin by PKC activators [37, 41]; and (iii)
Ets is up-regulated by PKC as well as by tyrosine kinases [41—43].
Ets proteins induced by PKC and/or tyrosine kinases could,
therefore, mediate the effect of IL-1f3 demonstrated here. Inter-
estingly, AP-1 complexes interact with c-Ets-i and function as
accessory molecules to achieve Ets-dependent transcriptional
activation [44]. This protein-protein interaction could explain the
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Fig. 6. Involvement of TRE, but not cAMP response element (CRE), in the
suppressive action of IL-I -inducible PKA on the stromelysin expression. A.
Effect of IL-113 on the activity of CRE. Mesangial cells were transiently
transfected with a CRE reporter plasmid pCRE-LacZ, stimulated with
IL-i/I for 24 hours, and X-gal assay was performed. For a positive control
study, a CRE activator dibutyryl cAMP (100 M) was used. An asterisk
indicates statistically significant difference (P < 0.05) compared to un-
stimulated control cells (—). B. Role of PKA on the basal activity of TRE.
Mesangial cells were transiently transfected with pTRE-LacZ, stimulated
by dibutyryl cAMP for 24 hours in the absence (—) or presence (+) of
HA1004 (10 ItM), and X-gal assay was performed. Asterisks show statis-
tically significant differences (P < 0.05).
IL-i
PKC
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Fig. 7. Schematic representation of opposite, binaty regulototy pathways
involved in IL-i -mediated stromelysin gene expression in rat mesangzal cells.
iL-I /3 up-regulates stromelysin transcription via the PKC-dependent
pathway under the cooperation with constitutively active TRE. This
stimulatory effect is in part counterbalanced by the IL-I-inducible PKA
which down-regulates the basal TRE activity.
negative regulator via CREM or CREB and counterbalanced the
increase in TRE activity. The lack of CRE activation by IL-1/3 in
the presence of activated PKA could also be explained by such a
cross-coupling of transacting molecules between TRE and CRE
[34]. Further investigation will be required to clarify these issues.
In summary, we demonstrated the unique binary regulatory
system involved in the IL-i-mediated stromelysin expression in
mesangial cells. Although the pathophysiological relevance of this
opposing dual control is unclear, the negative regulatory pathway
identified here could function as a "stopper" that restrains the
excessive responses of mesangial cells to proinflammatory stimuli
within the nephritic microenvironment.
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